‘One-Two Punch’ Targets Resistance Mechanism in Aggressive Triple-Negative Breast Cancer

Summary

Researchers identified a role for lysyl oxidase (LOX) in triple-negative breast cancer resistance and demonstrated that blocking LOX creates a vulnerability exploitable with a second drug, suggesting a potential combination therapy approach.